Condition
Premenopausal Breast Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Premenopausal Breast Cancer clinical trials that are recruiting, at sites in 9 countries (most in Taiwan (2), Spain (2), South Korea (1)). By phase: Phase 2 (3), Phase 4 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 9Countries
Newest Premenopausal Breast Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Personalized chemo decisions for young HR+/HER2- breast cancer patients | Phase 3 | Brussels and 104 other locations | Recruiting | Aug 6, 2025 |
| Neoadjuvant chemotherapy with or without hormone therapy for young women with triple-negative breast cancer | Phase 2 | Taipei | Recruiting | Jan 25, 2024 |
| Elacestrant alone or with triptorelin for premenopausal luminal (HR+/HER2−) breast cancer | Phase 2 | Badalona, Barcelona and 14 other locations | Recruiting | Aug 8, 2023 |
| Combination therapy for premenopausal women with advanced ER positive breast cancer | Phase 2 | Taipei | Recruiting | Feb 9, 2023 |
| Ovarian function suppression for premenopausal women with low-risk breast cancer | Phase 4 | Seoul, Korea and 1 other locations | Recruiting | Apr 18, 2022 |
All recruiting trials (5)
-
Personalized chemo decisions for young HR+/HER2- breast cancer patients
This trial tests whether using a genomic test can safely spare some premenopausal patients from chemotherapy in favor of endocrine therapy alone.
-
Neoadjuvant chemotherapy with or without hormone therapy for young women with triple-negative breast cancer
This study is testing if adding a hormone therapy to standard chemotherapy can help young women with triple-negative breast cancer respond better to treatment.
-
Elacestrant alone or with triptorelin for premenopausal luminal (HR+/HER2−) breast cancer
This trial will test whether the oral drug elacestrant, given alone or with triptorelin (and compared to tamoxifen in Part B), changes tumor biology in premenopausal women with operable hormone receptor–positive, HER2‑negative breast cancer.
-
Combination therapy for premenopausal women with advanced ER positive breast cancer
This study is testing different combinations of medications to see if they can help premenopausal women with advanced breast cancer that hasn't improved with previous treatments.
-
Ovarian function suppression for premenopausal women with low-risk breast cancer
This study is testing if lowering ovarian function with hormone treatments can help premenopausal women with low-risk breast cancer after surgery feel better and avoid chemotherapy.
Related topics
Quick answers
How many Premenopausal Breast Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in Taiwan (2 trials), Spain (2 trials), South Korea (1 trial), Belgium (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.